Investor Overview


GlobeImmune, Inc. is a privately held biopharmaceutical company established in 1995 focused on developing products for the treatment of cancer and infectious diseases based on our proprietary Tarmogen® platform.

Internal Revenue Service

Report of Organizational Actions Affecting Basis of Securities

2012 IRS Form 8937

2014 IRS Form 8937